Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.
Press releases published on April 29, 2025
BBSCF Student Perpetual Lanyo Selected to Perform for President of Ghana in Televised Event
EIN Presswire
·
April 29, 2025
A student from BBSCF performed for the President of Ghana in a televised event honoring the National Launch of Free Sanitary Pads for Girls in School. ACCRA, GHANA, April 29, 2025 /EINPresswire.com/ -- Perpetual Lanyo, a student from the Brigitte …
Wingu Africa Appoints Freddy Mrema as General Manager, Tanzania Sales
EIN Presswire
·
April 29, 2025
Wingu Africa appoints Freddy Mrema as GM of Tanzania Sales to drive growth and local partnerships, reinforcing its commitment to local leadership. DAR ES SALAAM, DAR ES SALAAM, TANZANIA, April 29, 2025 /EINPresswire.com/ -- Wingu Africa Appoints Freddy …
Perseus Mining March Quarter Report
GlobeNewswire
·
April 29, 2025
Perth, April 30, 2025 (GLOBE NEWSWIRE) -- MARCH 2025 QUARTER REPORT Strong performance of Perseus Mining’s operations continues, cash …
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
GlobeNewswire
·
April 29, 2025
SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of …
BridgeBio Reports First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
April 29, 2025
- $36.7 million in first full quarter of U.S. Attruby™ net product revenue and as of April 25, 2025, 2,072 unique patient prescriptions written by 756 unique prescribers - Observational run-in study for hypochondroplasia Phase 2 trial fully enrolled …
Decentralized OS Breakthrough: GNC (GRIDNET OS) Now Available on XT.COM
GlobeNewswire
·
April 29, 2025
VICTORIA ,Seychelles, April 29, 2025 (GLOBE NEWSWIRE) -- Dear XTers, XT.COM is pleased to announce that GNC (GRIDNET OS) is now live on our platform. The GNC/USDT trading pair is set to launch in the Innovation Zone (Web 3.0) at 12:00 UTC on April 30, 2025 …
BeMine Celebrates 7 Years with Gamified Mining Rewards and Token Airdrops
GlobeNewswire
·
April 29, 2025
Victoria, Seychelles, April 29, 2025 (GLOBE NEWSWIRE) -- Cloud mining provider BeMine.club is marking its 7th anniversary by launching a multi-week campaign focused on user rewards, interactive engagement, and special offers. “BeMine Birthday Bash” is …
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
GlobeNewswire
·
April 29, 2025
VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery, today …
Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting
GlobeNewswire
·
April 29, 2025
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …
Four-year Follow-up Data on SPRINT® PNS for Low Back Pain Highlights Sustained Pain Relief Avoiding Costly and Invasive Treatments
GlobeNewswire
·
April 29, 2025
CLEVELAND, April 29, 2025 (GLOBE NEWSWIRE) -- SPR announced the publication of long-term follow-up survey data from a prospective, multicenter study that demonstrated significant and sustained pain relief more than four years after treatment with 60-day …
Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 29, 2025
SOUTH SAN FRANCISCO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Incyclix Bio Granted U.S. FDA Fast Track Designation for INX-315 to Treat CCNE1-Amplified Platinum-Resistant/Refractory Ovarian Cancer
GlobeNewswire
·
April 29, 2025
RESEARCH TRIANGLE PARK, N.C., April 29, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer, today …
Nautilus Biotechnology Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 29, 2025
SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2025. “In Q1, …
Atsena Therapeutics to Present at May Scientific Conferences
GlobeNewswire
·
April 29, 2025
DURHAM, N.C., April 29, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced it will present at the following …
DATE CORRECTION – Amerigo will report Q1-2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 29, 2025
VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is issuing the following date correction, which was included in its Operational Results news release issued on …
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast
GlobeNewswire
·
April 29, 2025
SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter …
Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council
GlobeNewswire
·
April 29, 2025
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation OXFORD, UK and CLEVELAND, Ohio, US, 29 April 2025 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and …
Ocular Therapeutix™ to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire
·
April 29, 2025
BEDFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and scientific …